Introduction
Misfolded protein deposits of the amyloid beta peptide (Aβ) 1,2 and the microtubule-130 associated protein tau (tau) 3 are central pathological features in Alzheimer's Disease (AD), while 131 reduced brain glucose metabolism and synaptic density are more highly correlated with the 132 development of clinical cognitive dysfunction 4 . Preclinical research shows that diminished 133 glucose metabolism exacerbates learning and memory deficits, concurrent with the accumulation 134 of Aβ oligomers and plaques 5 , and misfolded, hyperphosphorylated tau 6,7 . However, the 135 interrelationships between and among these key pathological processes are largely unknown. 136 The decline in brain glucose metabolism in AD correlates with a reduction in the α-137 ketoglutarate dehydrogenase complex (KGDHC) 8 , a key control point in the tricarboxylic acid 138 (TCA) cycle. In yeast 9 and cultured neurons 10,11 , reduction in KGDHC activity leads to a wide-139 spread reduction in regional brain post-translational lysine succinylation, a recently discovered 140 post-translational modification (PTM). Studies of organisms deficient in NAD + -dependent 141 desuccinylase sirtuin 5 (SIRT5) 12 provide evidence of the regulatory importance of succinylation 142 in metabolic processes [13] [14] [15] [16] [17] . However, the role of succinylation in metabolic pathways of the 143 human nervous system or in neurodegenerative diseases is unknown. Our study represents the 144 first to report the human brain succinylome and characterize its changes in AD. The results 145 suggest that succinylation links the AD-related metabolic deficits to structural, functional and 146 pathological changes in APP and tau. 147 148 Succinylome and proteome of human brain 149 Analysis of two cohorts each consisting of brain tissues from five controls and five AD 150 patients (patient information is provided in Supplementary Table 1) was performed in order to 151 maximize our chances of optimizing the precision and reproducibility of the determinations of 152 the succinylome (Figure 1a, b ) and the proteome (Figure 1c, d) . When the two independent 153 cohorts were taken together, 1,908 succinylated peptides from 314 unique proteins were 154 identified across a total sample size of 20 brains (Figure 1b) . The parallel global proteomic 155 analysis detected 4,678 proteins (Figure 1d) . Nearly all of the succinylated proteins identified 156 during the study were found in the global proteome of the same samples (Figure 1e) . 157 Subcellular localization analysis of the 314 succinylated proteins from 20 human brains 158 facilitates an understanding of the implications of succinylation for cell function (Figure 2a and 159 Supplementary Table 2) . Succinylated proteins were one-to-many mapped to multiple 160 subcellular compartments. Among those, mitochondrial proteins were the most heavily 161 succinylated (Figure 2b) . About 73% (229/314) of the succinylated proteins were mitochondrial. 162 The pyruvate dehydrogenase complex (PDHC) E1 component subunit alpha (PDHA1), which 163 links glycolysis to the TCA cycle, was succinylated extensively. All eight enzymes of the TCA 164 cycle in the mitochondrial matrix and their multiple subunits, were also succinylated extensively. 165 Succinylated proteins were also associated with the cytosol (30%, 95 proteins) and nucleus 166 (23%, 73 proteins) (Figure 2b) . The overall distribution resembled that reported for 167 succinylated proteins in mouse liver 16, 17 . 168 The number of succinylation sites per protein varied from 1 to 23 (Figure 2c Table 2 in red). In general, these succinylated proteins typically appeared in 176 metabolism-associated processes and were linked to multiple disease pathways in KEGG 177 enrichment analysis (Extended Data Figure 1 and Supplement Table 3 ). 178 Since no specific motifs for lysine succinylation in human cells have been reported, a 179 succinylation motif analysis of all 1908 succinylated peptides using Motif-X 18 was used to assess 180 whether specific motif sites exist. A total of five conserved motifs were identified (Figure 2d) . A 181 survey of these motifs suggested that non-polar, aliphatic residues including alanine, valine and 182 isoleucine surround the succinylated lysines. Succinylated lysine site analysis revealed a strong 183 bias for alanine residues, which is consistent with motifs identified in tomato 14 . IceLogo 19 heat 184 maps assessed the preference of each residue in the position of a 15 amino acid-long sequence 185 context (Figure 2e) . Isoleucine was detected downstream of lysine-succinylation sites, while 186 alanine and lysine, two of the most conserved amino acid residues, were found upstream. 187 Meanwhile, valine residues occurred upstream and downstream. By contrast, there was only a 188 very small chance that tryptophan, proline or serine residues occurred in the succinylated 189 peptides. Figure 2a ). 209 The overwhelming majority (16/19) of the peptides with AD-related decreases in 210 succinylation were mitochondrial, and more than half of them showed exclusive localization in 211 mitochondria ( Supplementary Table 5 ). A novel association of the ATP5H/KCTD2 locus with 212 AD has been reported 20 , and ATP-synthase activity declines in AD brains 21 . In line with these 213 findings, we identified the maximal AD-related decrease (-1.33 in log2FC) in ATP synthase (Figures 3a, 3b) . 219 The largest AD-related increases in succinylation were in non-mitochondrial proteins 220 (Figures 3a, 3b ). Succinylation of four peptides from brain cytosolic and/or extracellular 221 hemoglobin subunits alpha and beta increased by 1.91-(0.978 in log2FC) to 2.18-fold (1.127 in 222 log2FC) with AD. Strikingly, two extra-mitochondrial peptides with the largest AD-related 223 increases in succinylation were from two proteins critical to AD pathology: APP and tau. Both 224 proteins were highly succinylated at critical sites in nine out of ten AD brain samples, but no 225 succinylation of APP or tau was detectable in any control brains (Figures 5, 6 ). 
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In subsequent experiments, we tested the relationship between succinylation and APP 261 processing by the secretase enzymes. K687-L688 is the APP α-secretase cleavage bond, and a 262 missense mutation at K687N produces an early onset dementia 25 . Furthermore, global 263 proteomics showed an increase of β-secretase (BACE1) abundance of 31% in AD brains Figure 4c) . Surprisingly, at peptide concentration of 10 μM in the presence of 2.5 μM 316 heparin, neither PHF6* nor A-PHF6* fibrillated during an 80-min incubation period. Although 317 PHF6* is an initiation site for tau aggregation, its potency is much lower than that of PHF6 37 , 318 possibly explaining the observed lack of aggregation under these conditions. In contrast, PHF6 (Figure 6e) . Longer (24-hour incubations) of PHF6, S-PHF6, and a 90%/10% mixture 324 were visualized by EM (Figure 6f-h) . All the reactions exhibited fibrils with a typical paired 325 helical filament appearance. However, the succinylated peptide formed abundant, short and 326 chaotic filaments, characteristics of brain-derived Alzheimer PHFs 38-40 , while unmodified PHF6 327 filaments are longer and sparser, morphologies more typical of recombinant tau peptide fibers 328 (Figure 6i and 6j) . Figure   347 4g-i) largely abrogated intensity decreases in spectra collected in the presence vs. absence T2R, 348 with increased intensity ratios compared to unmodified K19 across all residues (Figure 6m) . 349 This indicates that succinylation of K19 weakens the interaction with the T2R tubulin tetramer. 350 To establish whether succinylation of K311 was sufficient to specifically decrease tau- Cornell Medicine) for help with NMR experiments. 412 We thank E. Ivanova and Structural and Functional Imaging Core at the Burke Neurological 413 Institute for the technical assistance. 414 We are grateful to the NIH Neurobiobank for providing the carefully characterized human 415 brains. 416 We thank Dr. R. Kayed Table 4) . 7 c. A schematic diagram of the workflow for quantitative proteomics of human brain by Tandem 8 mass tags (TMT) labeling analysis (See methods section). 9 d. After quantitative data screening and mining, the combined results from 20 brain samples in 10 two batches revealed 4,442 common proteins in both AD and controls ( Supplementary Table 6 ). 11 Eighty-one proteins showed significant alterations between samples patients with AD and 12 controls. 13 e. The overlap between succinylomes and proteomes. Nearly all of the succinylated proteins were 14 also identified in its global proteomic analysis. 15 
